These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
353 related items for PubMed ID: 28881518
21. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus. Cashell J, Smink GM, Helm K, Xavier F. Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028 [Abstract] [Full Text] [Related]
22. Sirolimus therapy for kaposiform hemangioendothelioma with long-term follow-up. Wang Z, Yao W, Sun H, Dong K, Ma Y, Chen L, Zheng S, Li K. J Dermatol; 2019 Nov; 46(11):956-961. PubMed ID: 31489702 [Abstract] [Full Text] [Related]
28. Role of Sirolimus in Advanced Kaposiform Hemangioendothelioma. Oza VS, Mamlouk MD, Hess CP, Mathes EF, Frieden IJ. Pediatr Dermatol; 2016 Apr; 33(2):e88-92. PubMed ID: 26864138 [Abstract] [Full Text] [Related]
29. Clinicopathological features of Kaposiform hemangioendothelioma. Liu Q, Jiang L, Wu D, Kan Y, Fu F, Zhang D, Gong Y, Wang Y, Dong C, Kong L. Int J Clin Exp Pathol; 2015 Apr; 8(10):13711-8. PubMed ID: 26722599 [Abstract] [Full Text] [Related]
30. Sirolimus, a promising treatment for refractory Kaposiform hemangioendothelioma. Kai L, Wang Z, Yao W, Dong K, Xiao X. J Cancer Res Clin Oncol; 2014 Mar; 140(3):471-6. PubMed ID: 24464150 [Abstract] [Full Text] [Related]
31. Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma. Drolet BA, Trenor CC, Brandão LR, Chiu YE, Chun RH, Dasgupta R, Garzon MC, Hammill AM, Johnson CM, Tlougan B, Blei F, David M, Elluru R, Frieden IJ, Friedlander SF, Iacobas I, Jensen JN, King DM, Lee MT, Nelson S, Patel M, Pope E, Powell J, Seefeldt M, Siegel DH, Kelly M, Adams DM. J Pediatr; 2013 Jul; 163(1):285-91. PubMed ID: 23796341 [No Abstract] [Full Text] [Related]
32. Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial. Ji Y, Chen S, Zhou J, Yang K, Zhang X, Xiang B, Qiu T, Gong X, Zhang Z, Lan Y, Hu F, Kong F, Qiu Q, Zhang Y. Blood; 2022 Mar 17; 139(11):1619-1630. PubMed ID: 35030255 [Abstract] [Full Text] [Related]
33. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon. Mariani LG, Schmitt IR, Garcia CD, Kiszewski AE. Pediatr Blood Cancer; 2019 Aug 17; 66(8):e27810. PubMed ID: 31087627 [No Abstract] [Full Text] [Related]
34. Recurrent multifocal cutaneous Kaposiform hemangioendothelioma: A rare vascular tumor of infancy and childhood. Atla B, Sudhakar PV, Rao N, Prasad U. Indian J Pathol Microbiol; 2016 Aug 17; 59(3):392-4. PubMed ID: 27510687 [Abstract] [Full Text] [Related]
36. Kaposiform hemangioendothelioma without cutaneous involvement. Ji Y, Chen S, Li L, Yang K, Xia C, Li L, Yang G, Kong F, Lu G, Liu X. J Cancer Res Clin Oncol; 2018 Dec 17; 144(12):2475-2484. PubMed ID: 30293120 [Abstract] [Full Text] [Related]
37. Kaposiform hemangioendothelioma in tonsil of a child associated with cervical lymphangioma: a rare case report. Rekhi B, Sethi S, Kulkarni SS, Jambhekar NA. World J Surg Oncol; 2011 May 23; 9():57. PubMed ID: 21605441 [Abstract] [Full Text] [Related]
38. Efficacy of transcatheter arterial chemoembolization combined with sirolimus for treating Kasabach-Merritt phenomenon in infants, a retrospective study. Yin CG, Qi WW, Wang S, Pan D, Chen XL, Li SY. Ann Med; 2023 Dec 23; 55(1):2196090. PubMed ID: 37038342 [Abstract] [Full Text] [Related]
40. Intracranial kaposiform hemangioendothelioma presenting as epistaxis: a rare case report with review of literature. Das S, Deora H, Rao S, Kandregula S, Narayana SM. Childs Nerv Syst; 2021 Jun 23; 37(6):2057-2062. PubMed ID: 32989498 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]